摘要
目的研究在长春瑞滨(Vinorelbine,NVB)加顺铂(Cisplatin,DDP)方案基础上进一步针对病理学分类和癌细胞分化程度的系列联合化疗方案治疗非小细胞肺癌(nonsmalcellungcancer,NSCLC)的疗效。方法低、中分化程度的肺鳞癌和低分化肺腺癌仍采用基础方案即NVB+DDP方案治疗,高分化肺鳞癌在基础方案之上加用博莱霉素(BLM),中、高分化肺腺癌在基础方案之上加用多柔比星(阿霉素,ADM)。50例NSCLC中,男性27例,女性23例。腺癌30例,低、中、高分化程度分别为13、11和6例;鳞癌16例,低、中、高分化程度分别为5、6和5例;混合型病理诊断3例,均为低分化程度。Ⅲb期32例,Ⅳ期18例。结果完全缓解(CR)4例,部分缓解(PR)29例,稳定(S)13例,进展(P)4例,总有效率为66%。中位缓解期39月,KaplanMeier估计半数死亡概率为12个月。系列方案的剂量限制性毒性为骨髓抑制,发生率为100%,注药局部反应发生率为48%。结论NVB抗非小细胞肺癌治疗疗效确切,在NVB+DDP联合化疗方案中适当增加抗癌药物品种似可增加疗效。
PURPOSE To observe further the efficacy of vinorelbine(navelbine) in the treatment of non small cell lung cancer(NSCLC) with a series of schemes in combination with other anticancer drugs which were used as based on pathological classification and cancer cell atypia. METHODS Vinorelbine (NVB)+cisplatin (DDP) were used in the treatment of patients with moderate or loady differentiated squameous or(and)undiferentiated adenocarcima as a basic combination chemotherapy scheme, and NVB+DDP+bleomycin(BLM) in the patients with highly differentiated squamous carcinoma NVB+DDP+doxorubicin(ADM) in moderately and hihgly differentiated adenocarcinoma. 50 cases were treated,with 27 cases male and 23 female. Of these 30 patients lung adenocarcinomas,16 were squamous,4 others unknown. Staging:Ⅲb 32 cases,Ⅳ 18 cases. RESULTS Among the 50 patients treated there are 4 CR,29 PR,13 NC and 4 PD, with a total effective rate of 66%. The median time of remission was 3.9 months.The probability value of half lethal time was 12 months following anticancer drug withdrawal.The main ADRs of combined chemotherapy were bone marrow suppression which took place in all of patients.There were 48% of cases with phlebitis. CONCLUSION The efficacy of navelbine in the treatment of advanced non small cell lung cancer is comparable with those previously reported;while the role of DDP+NVB combined with ADM/BLM is worthy of further observation.
出处
《中国癌症杂志》
CAS
CSCD
1999年第2期121-124,共4页
China Oncology
关键词
非小细胞肺癌
长春瑞滨
顺铂
化疗
Non small cell lung cancer Vinorelbine Cisplatin Chemotherapy